Skip to main content

NC Puts 10 Companies on SEBIO Forum Stages

Photo by Tim McKay

Ten innovative North Carolina life science companies are among the 26 chosen to pitch technologies and plans Nov. 6 and 7 at the 2013 Southeast BIO Investor & Partnering Forum in Richmond, Virginia.

The event, co-sponsored by the North Carolina Biotechnology Center at the iconic Jefferson Hotel, provides a showcase for some of the most promising bioscience and medical technology companies in the seven-state region, which also includes Alabama, Florida, Georgia, South Carolina, Tennessee, and Virginia.

The event gives executives of young companies picked by a selection committee of regional and national venture capitalists a chance to collect advice and investment.

One group of companies, dubbed MAIN/Stage presenting companies, have generally completed at least one round of institutional financing. They will each make a 10-minute pitch to the full conference audience on Wednesday afternoon, November 6.

Companies in the EARLY/Stage event are seeking their first rounds of investment. They will participate in an individual private advisory session led by early-stage investors, entrepreneurs and experienced life science managers and service providers. Four EARLY/Stage companies will be selected to present to the full conference audience, with an overall "winner" announced at the closing lunch.

There's also a BIO/Plan competition with four contenders, one of which is PleX Diagnostics, a Triangle-area UNC spinout developing a diagnostic test for liver cancer. PleX and the other finalists will present their business opportunities to the audience and to a panel of celebrity judges. Judges will score the participants and add their scores to the earlier written development plan scores to determine the winner of the plan competition. The BIO/Plan winner will also be announced at the Closing Luncheon

NC companies giving MAIN/Stage presentations are:

  • G1 Therapeutics of Chapel Hill, developing therapeutics to protect bone marrow from damage due to chemotherapy or radiation;
  • Pique Therapeutics, of Durham, developing therapeutic vaccines to treat cancer.

EARLY/Stage presenters from NC include:

  • Ardeal Pharma, of Brevard, developing treatments for dermal, pharmaceutical and cosmetic markets based on Stabilized Sulforaphane;
  • Camras Vision of Research Triangle Park, developing personalized care treatment for glaucoma patients to stop vision loss;
  • CanDiag of Charlotte, developing cancer screening technology for early detection of breast cancer;
  • Eboo Pharmaceuticals of Durham, developing  pharmaceutical compounds for Parkinson’s disease and other indications;
  • NIRvana Sciences of RTP, developing novel dyes with ultra-narrow spectral properties;
  • Novocor Medical Systems of Raleigh, developing a rapid-chilling device to induce therapeutic hypothermia;
  • T3D Therapeutics of RTP, developing therapeutic to treat Alzheimer’s disease.

Registration remains open for the November event.

Add new comment

Type the characters you see in this picture.
Type the characters you see in the picture; if you can't read them, submit the form and a new image will be generated. Not case sensitive.  Switch to audio verification.